Gerresheimer AG (GRRMY)
OTCMKTS · Delayed Price · Currency is USD
12.69
0.00 (0.00%)
Sep 12, 2025, 4:00 PM EDT
Gerresheimer AG Market Cap
Gerresheimer AG has a market cap or net worth of $1.71 billion as of September 12, 2025. Its market cap has decreased by -56.86% in one year.
Market Cap
1.71B
Enterprise Value
4.26B
Revenue
2.48B
Ranking
n/a
PE Ratio
23.82
Stock Price
$12.69
Market Cap Chart
Since June 11, 2007, Gerresheimer AG's market cap has increased from 1.61B to 1.71B, an increase of 6.27%. That is a compound annual growth rate of 0.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.71B | -32.80% |
| Dec 30, 2024 | 2.54B | -29.36% |
| Dec 29, 2023 | 3.60B | 70.93% |
| Dec 30, 2022 | 2.11B | -30.02% |
| Dec 30, 2021 | 3.01B | -11.06% |
| Dec 30, 2020 | 3.39B | 39.32% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 739.21M |
| Elite Pharmaceuticals | 737.49M |
| Glass House Brands | 577.09M |
| Northwest Biotherapeutics | 376.88M |
| CytoDyn | 367.97M |
| American Oncology Network | 353.52M |